Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Transcatheter Aortic Valve Implantation Indications and Patient Selection
Author(s): Jonathan Curio , Henning Guthoff , Stephan Nienaber , et al Added: 1 month ago

Vascular Disease and Surgery
CRT 25: The PARTNER 3 Registry
Author(s): S. Chris Malaisrie Added: 4 months ago
CRT 25 - Dr S. Chris Malaisrie (Northwestern University, Evanston, US) joins us to discuss the five-year outcomes from the PARTNER 3 aortic valve-in-valve registry (NCT02675114). The prospective, randomized, multi-center study aimed to assess TAVR with the Edwards SAPIEN 3 transcatheter heart valve (Edwards Lifesciences) compared to aortic valve replacement with a commercially available surgical… View more

Intervention
Aortic Valve Calcium, Aortic Stenosis and TAVI
Author(s): James Krzowski , Jonathan Weir-McCall , Luigia D’Errico , et al Added: 2 months ago

Imaging & Diagnostics

Intervention
Geographical Inequality in Access to Aortic Valve Intervention in England
Author(s): Suleman Aktaa , Noman Ali , Peter F Ludman , et al Added: 10 months ago

Intervention
Gadolinium-guided Transcatheter Aortic Valve Implantation
Author(s): Bandar Alshehri , Hussein Alamri , Naif Alghasab , et al Added: 5 months ago

CV Disease in Special Populations

Intervention
NY Valves 25: Early Outcomes of TAVI Valve with Intra-Annular Leaflet Position
Author(s): Santiago Garcia Added: 2 weeks ago
New York Valves 2025 -Dr Santiago Garcia (The Christ Hospital, Cincinnati, OH, US) joins us to discuss outcomes from an observational study investigating early outcomes of the Navitor self-expandable transcatheter valve with intra-annular leaflet position. Approximately 3,000 patients with severe, symptomatic aortic stenosis, high surgical risk and tricuspid anatomy were enrolled in the study and… View more

Intervention
Management of CAD in TAVI
Author(s): Cian Murray , Caoimhe Ryan , Michael Cronin , et al Added: 1 month ago

Intervention
NY Valves 25: TAVR in 2025: How Can We Do Better?
Author(s): Ole De Backer Added: 3 weeks ago
New York Valves 2025 - Prof Ole De Backer (Rigshospitalet, Copenhagen, DK) joins us to discuss the current landscape of transcatheter aortic valve replacement (TAVR) in 2025. Prof De Backer highlights the recent trends in current TAVR research and shares his anticipations and hopes for the future of the procedure.Interview Questions:1. What does the TAVR landscape look like in 2025, and how has… View more

Intervention
New York Valves 2025
Author(s): Paul Grayburn Added: 3 weeks ago
Don't miss our late-breaking coverage of New York Valves 2025 Summit, including Expert Interviews offering insights into key data and their future impact on clinical practice. View more

Imaging & Diagnostics

Intervention
NY Valves 25: Lifetime Management in TAVR Patients
Author(s): Tanush Gupta Added: 3 weeks ago
New York Valves 25 - Dr Tanush Gupta (UVM Medical Center, Burlington, VT, US) joins us to discuss key conversations around lifetime management for transcatheter aortic valve replacement (TAVR) patients. He discusses key data from the NOTION trial and how this has influenced his practice, as well emerging technologies such as AI simulation models and new valves.Interview Questions:How has FDA… View more

Intervention